Shire Share Discussion Threads

[scfc1] 22/4/2018 00:27

That's correct but clearly there was a reduction in the share proportion as well. Bottom line is that it was an increase in price of c1% only, albeit now with a different split. It is clear you're hoping for a deal and of course it may well happen but personally I think Takeda would be stretching their finances far too much with expected debt on their new balance sheet of well in excess of $50bn. What is a little odd imo as if the 2 sets of advisors were discussing a possible deal, why it wasn't thrashed out and publicly announced as a deal (or that no deal could be made)...why was it announced by Takeda as an offer and then acknowledged by Shire's BODs to be considered in due course...presumably a Board Meeting will be taking place ASAP, if it's not happened already. Monday will be very interesting!

[karateboy] 21/4/2018 21:25

This is what SHP said after rejecting the third offer:'' At the request of the board Shire advisors entered into a dialogue with Takeda's advisors to discuss whether a further more attractive proposal may be forthcoming...'' Then 4th offer put to SHP with cash element increased by 18% .

[mbmiah] 21/4/2018 20:32

*meditations.....that's what you meant really, your keyboard predicts it from a habitual algorithm. Made me lol

[scfc1] 21/4/2018 17:30

*mediations!

[scfc1] 21/4/2018 17:29

I've done plenty of negotiating in my time in the corporate world esp. in meditations...but making a clear public statement to shareholders and Stock Exchange, etc, is quite different. Let's see what happens as the bottom line is, none of us know! ATB.

[dealy] 21/4/2018 16:23

It's just negotiating tactics

[scfc1] 21/4/2018 16:06

I don't disagree that the cash increase is predominantly for the S-Ts. My point was how this can be not seen by the BODs as significantly undervalued if an offer of c1% lower was seen as such 3 days ago.

[dealy] 21/4/2018 15:50

The cash part is to appease the short termers I.e. UK pension fund managers

[scfc1] 21/4/2018 14:36

That argument makes no sense. The new offer has actually offered more cash than before (as compared with the paper shares).

[dealy] 21/4/2018 14:15

The undervalued argument only works with a cash sell out. Maintaining an interest in the newco still leaves access to the underlying value in both companies plus the synergy effects

[scfc1] 21/4/2018 14:00

I can understand why many think/hope £47/share maybe accepted but it remains very difficult to reconcile this with the BOD issued statement only a few days ago that £46.50 significantly undervalued the company...this increase is just over 1% from Offer 3 and can hardly be seen as significant. Who knows!

[suffersnofools] 21/4/2018 11:30

I'd expect them to accept if it's advisors rec.

[karateboy] 21/4/2018 08:51

SHP board should be very careful not to push Takeda too hard that puts dividend or investment ranking of the combined company at risk. After all we still will be owning half the company with a better management, better reputations to look after stake holders and much much better dividend . I will take the cash and keep my new shares in the new company to get 3% dividend.

[dealy] 21/4/2018 08:22

Synergy effects of such a merger will be significant. 1 +1 equals 2.5. Dual listing of Takeda stock will solve the paper problem. I also reckon with the deal going through and the stock moving towards 4300 next week allowing for some slippage in Takeda share price and deal approval uncertainty

[karateboy] 21/4/2018 08:04

SHP won't turned the offer down. If we don't hear on Monday, SHP must be still talking to Takeda to clarify few points here or there. Allergan did a great favour by withdrawing its offer. If Allergan stayed in , That would have given false sense of security to SHP that there is another bidder, we all know Allergan with $30b debts can't afford SHP. I believe this is the end of SHP and Tekeda bid will succeed but it may go to the wire. Boys and girls close your shorts on Monday, while you may still have time.

[philanderer] 21/4/2018 00:19

FT:

Paul Major, fund manager at BB Healthcare Trust, which has 5.7 per cent of its £280m fund invested in Shire, said if Shire’s management did turn the bid down, this could be hard to explain to investors as it was “not immediately obvious anyone else is waiting in the wings”.

[philanderer] 21/4/2018 00:13

MARKET REPORT: Fourth swoop on Shire as Japan's largest drugs firm Takeda bids £43bn... but shares fall 3.9%


Takeda, Japan's largest pharmaceutical company, just won't take no for an answer.

Having had three bids for the Irish drug maker Shire turned down, it returned with an improved fourth yesterday.

The new offer values Shire at £47 a share, or £42.8billion, a near-£500million improvement on its last bid.

Botox maker Allergan was also in the running to buy the FTSE 100 firm before pulling out of the race on Thursday in a takeover pursuit that is beginning to rival a soap opera for drama.

If Takeda succeeds with its latest bid, it will go down as one of the pharmaceutical sector's largest-ever deals.

Before Takeda's latest approach, analysts claimed a deal for Shire was all but dead in the water.

But it raises hopes that a deal can be thrashed out before the 5pm deadline on April 25.

Takeda said: 'Takeda believes the improved proposal represents a highly compelling opportunity for Shire shareholders.'

Despite the new bid, Shire's shares fell 3.9 per cent ,or 153.5p, to 3821.5p, wiping £1.4billion off its value.

[mbmiah] 20/4/2018 22:19

The market doesn't believe the bod will accept the bid hence the lower share price. Once there is indication of acceptance or a rival bidder then the share price will rocket. Place your sell orders boys!!!

[romeike] 20/4/2018 22:12

It may have closed higher but it is trading at a huge discount to the bid.

[karateboy] 20/4/2018 21:32

Good luck to holders . We may get a RNS this weekend. USA market closed higher so market putting more weight on SHP accepting the offer than rejecting it. There is nothing we can do now except wait and see.

[philanderer] 20/4/2018 21:05

Closing USA just above 3900p

[blueclyde] 20/4/2018 21:01

No you won't be able to sell at that price hence why this deal won't go through. It's not unrealistic that if say a price of £47 agreed then Takeda shares sell off due to over leverage fears an fall 15 to 20% then suddenly your new takeda shares are worth less than the current Shire share price. I can't see how anyone would agree to this?

[ny boy] 20/4/2018 20:31

So if the board accept this revised offer, equivalent of 4700p does that mean you can sell your shares at this price?

[scfc1] 20/4/2018 19:54

Just under £39 but quite volatile